Custom Index Systems’s Biogen BIIB Stock Holding History

Custom Index Systems’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-941	Closed	-$218K	–	242
2024 Q2	$218K	Buy	+941	New	+$205K	0.13%	224

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Custom Index Systems's BIIB Position: Q3 2024 in Review

Custom Index Systems sold out of Biogen (BIIB) in Q3 2024, closing a stake of 941 shares — an estimated $218K sold.

Custom Index Systems first reported a position in BIIB in Q2 2024 and held it in 1 quarter. The position peaked at $218K in Q2 2024. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Custom Index Systems reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
Custom Index Systems sold 941 Biogen shares in Q3 2024, an estimated $218K.
Custom Index Systems first reported a position in Biogen in Q2 2024 and held it in 1 quarter.
Custom Index Systems's Biogen position peaked at $218K in Q2 2024.
916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Custom Index Systems's 13F filing for Q3 2024, filed 24 Oct 2024.